GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: Three case reports

Fertility and Sterility

Volumn 95, Issue 7, 2011, Pages 2432.e17-2432.e19

  Martínez, Francisca ^a,b   Rodríguez, Dalia Beatriz ^a   Buxaderas, Rosario ^a   Tur, Rosa ^a   Mancini, Fulvia ^a   Coroleu, Buenaventura ^a  

^a Salud de la Mujer Dexeus   (Spain)

^b INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

agonist trigger; antagonist rescue; IVF; long protocol; OHSS

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTROGEN; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HIGH RISK PATIENT; HOSPITAL; HUMAN; INJECTION; INTRACYTOPLASMIC SPERM INJECTION; MENSTRUAL CYCLE; OOCYTE; OVARY HYPERSTIMULATION; OVULATION; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; SAFETY; SPERM; URINE;

EID: 79956340012     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.03.083     Document Type: Article

References (9)

1. A.N. Andersen, V. Goossens, and A.P. Ferraretti Assisted reproductive technology in Europe: results generated from European registers by ESHRE Hum Reprod 23 2008 756 771
2. P. Humaidan, J. Quartarolo, and E.G. Papanikolaou Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil Steril 94 2010 389 400
3. R.L. Gustafson, J.H. Segars, and F.W. Larsen Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome Hum Reprod 11 2006 2830 2837 (Pubitemid 44566994)
4. M. Aboulghar A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS Reprod Biomed Online 15 2007 271 279 (Pubitemid 47430366)
5. J. Kwee, M.E. Elting, R. Schats, J. McDonell, and C.B. Lmbalk Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization Reprod Biomed Online 15 2007 5 9
6. T.H. Lee, C.H. Liu, C.C. Huang, Y.L. Wu, Y.T. Shih, and H.N. Ho Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum Reprod 23 2008 160 167
7. D. Bodri, J.J. Guillén, M. Trullenque, K. Schwenn, C. Esteve, and O. Coll Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study Fertil Steril 93 2010 2418 2420
8. H. Abdalla, and J.D.M. Nicopoullos The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation Fertil Steril 94 2010 1757 1763
9. G. Griesinger, L. Schultz, T. Bauer, A. Broessner, T. Frambach, and S. Kissler Ovarian hypertimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin- releasing hormone antagonist protocol in combination with a "free-all" strategy: a prospective multicentric study Fertil Steril 95 2011 2029 2033